Bill · H.R. 1414· House(119-HR-1414)

Cameron’s Law

Age: 51 years

New Jersey

Introduced: 2/18/2025
Last activity: 2/18/2025 — Referred to the House Committee on Ways and Means.
Sponsored by: Josh Gottheimer
Cosponsors: - 8 - 11

Taxation

Introduced
In Committee

What this bill would do

This bill, titled Cameron's Law'', aims to amend the Internal Revenue Code of 1986. The primary purpose is to restore the amount of the orphan drug tax credit. Specifically, it proposes to change the credit rate from 25 percent'' to ``50 percent''. This change applies to Section 45C(a) of the Internal Revenue Code. The new rate would be effective for taxable years beginning after the Act is enacted.

Yes· 3 of 6

Would business owners be better off under this?+5
Pharmaceutical company owners benefit from the increased tax credit for orphan drugs.
Does this put more money into medical research?+4
The expansion of the tax credit functions as a form of indirect funding for the research and development of orphan drugs.
Does this put more money into scientific research?+4
The increased credit incentivizes pharmaceutical research into rare diseases.

The opposite

Does this reduce what the federal government spends?-3
Increasing the tax credit rate reduces federal tax revenue.

Who it would affect, and how

Potential Positive Impacts for People

Increased Orphan Drug Tax Credit: The bill increases the tax credit amount by striking 25 percent'' and inserting 50 percent'' in Section 45C(a) of the Internal Revenue Code of 1986. This represents a restoration of the credit amount.

Groups and Interests Ranking

Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.

Healthcare: Increases Research Funding+4Reduces Prescription Drug Costs+3Improves Healthcare Access+2
Demographic And Interest Groups: Good For Business Owners+5Good For High Income Households+2
Education And Technology: Increases Scientific Research Funding+4
Economy And Finance: Reduces Government Spending-3